Diphyllobothrium mansonoides
Diphyllobothrium mansonoides is a species of parasitic worm that belongs to the family Diphyllobothriidae. It is a type of tapeworm that primarily infects mammals, including humans.
Life Cycle[edit]
The life cycle of Diphyllobothrium mansonoides involves several stages. The adult worm resides in the small intestine of the definitive host, where it produces eggs that are passed in the feces. These eggs then hatch in water, releasing a ciliated larva known as a coracidium. The coracidium is ingested by a copepod, a small crustacean, where it develops into a procercoid larva. The infected copepod is then consumed by a second intermediate host, typically a small fish, where the procercoid develops into a plerocercoid larva. This larva is the infective stage for the definitive host, which becomes infected by consuming raw or undercooked fish containing the plerocercoid larvae.
Clinical Manifestations[edit]
Infection with Diphyllobothrium mansonoides can lead to a condition known as diphyllobothriasis. This is characterized by abdominal discomfort, diarrhea, nausea, and vomiting. In severe cases, the infection can lead to vitamin B12 deficiency, which can result in megaloblastic anemia.
Diagnosis and Treatment[edit]
Diagnosis of Diphyllobothrium mansonoides infection is typically made by identifying the characteristic eggs or segments of the worm in a stool sample. Treatment usually involves the administration of a single dose of praziquantel, a medication that is effective against a wide range of parasitic worms.
Prevention[edit]
Prevention of Diphyllobothrium mansonoides infection primarily involves avoiding the consumption of raw or undercooked fish. In areas where the parasite is common, fish should be thoroughly cooked or frozen before consumption to kill any larvae.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian